Craig Adam R 4
4 · X4 Pharmaceuticals, Inc · Filed Oct 27, 2025
Insider Transaction Report
Form 4
Craig Adam R
DirectorExecutive Chairman
Transactions
- Purchase
Common Stock
2025-10-23$2.90/sh+86,206$249,997→ 376,087 total
Footnotes (1)
- [F1]Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering.